Papi, M <br/><br/>
Clinically approved PEGylated nanoparticles are covered by a protein corona that boosts the uptake by cancer cells.  [electronic resource] 

 -  Nanoscale  Jul 2017 
 - 10327-10334 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2040-3372 
<br/><br/><label>Standard No.: </label>10.1039/c7nr03042h  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--administration & dosage<br/>Cell Line, Tumor<br/>Drug Delivery Systems<br/>Humans<br/>Liposomes<br/>Nanoparticles--chemistry<br/>Polyethylene Glycols--chemistry<br/>Protein Corona